Cipro-A Injection 200 mg/100 ml contains Ciprofloxacin, a broad-spectrum fluoroquinolone antibiotic formulated for intravenous use. This preparation is primarily used for the treatment of moderate to severe bacterial infections where oral therapy is not feasible, or rapid systemic delivery of the drug is required. By targeting bacterial DNA replication, Cipro-A Injection helps control infection quickly, reduce symptoms, and prevent potential complications.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Each 100 ml of infusion contains:
Ciprofloxacin 200 mg
Cipro-A Injection 200 mg/100 ml is indicated for the treatment of infections caused by susceptible bacteria, including:
Complicated urinary tract infections and pyelonephritis
Severe respiratory tract infections, including pneumonia and bronchitis exacerbations
Gastrointestinal infections such as typhoid fever and bacterial diarrhea
Skin and soft tissue infections
Bone and joint infections
Intra-abdominal infections including peritonitis
Septicemia and other systemic bacterial infections
Situations where oral administration is not possible or effective
Ciprofloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication, transcription, and repair. By interfering with these enzymes, the drug prevents bacterial proliferation and induces bacterial cell death. Its bactericidal activity and broad-spectrum efficacy make it highly effective in managing serious and systemic infections.
Broad-spectrum antibacterial coverage
Rapid systemic action via intravenous administration
Effective in severe and complicated infections
Useful for patients unable to take oral antibiotics
Clinically validated safety and efficacy profile
The dosage and infusion rate of Cipro-A Injection 200 mg/100 ml depend on the severity and type of infection, patient age, body weight, and kidney function. It should be administered under strict medical supervision. The infusion is usually given over 30 to 60 minutes to prevent rapid administration-related side effects. Adequate hydration is recommended during therapy to prevent potential renal complications. Transition to oral therapy may be considered once the patient’s condition stabilizes.
Cipro-A Injection should be used with caution in patients with a history of tendon disorders, epilepsy, cardiac conditions, or central nervous system disorders. Serious side effects may include tendonitis, tendon rupture, peripheral neuropathy, or hypersensitivity reactions, though these are rare.
Common side effects include nausea, vomiting, diarrhea, headache, dizziness, and local irritation at the injection site. Patients should be monitored for allergic reactions or unusual symptoms during therapy.
Ciprofloxacin may interact with antacids containing magnesium or aluminum, iron supplements, calcium products, zinc preparations, theophylline, warfarin, and certain antiarrhythmics. Careful monitoring or adjustment may be required when used concomitantly with these drugs.
Elderly patients: May require monitoring due to increased risk of tendon and CNS-related side effects.
Patients with renal impairment: Dose adjustment is necessary.
Pregnancy and lactation: Use only if clearly indicated and under medical supervision.
Store Cipro-A Injection 200 mg/100 ml in a cool, dry place away from light. Do not freeze. Use only if the solution is clear and the container is intact. Keep out of reach of children.
Cipro-A Injection 200 mg/100 ml (Ciprofloxacin) is a potent intravenous antibiotic for the rapid and effective management of moderate to severe bacterial infections. Its broad-spectrum action, rapid systemic delivery, and clinical reliability make it essential for patients requiring urgent antibacterial therapy under professional supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet